SINGAPORE-BASED Genesis Alternative Ventures on Thursday said it has closed its first fund at US$80 million, exceeding its initial target of some US$70 million.
Read more here.
SINGAPORE-BASED Genesis Alternative Ventures on Thursday said it has closed its first fund at US$80 million, exceeding its initial target of some US$70 million.
Read more here.
![[Zebra in The Jerusalem Post] Zebra Medical wins FDA clearance for AI Intracranial hemorrhage detection](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
